PRESS RELEASE published on 02/04/2025 at 14:03, 1 year 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares total shares and voting rights. Announcement confirms 97,330,405 shares and 165,560,444 voting rights as of Jan 1, 2025 Voting Rights Capital Shares Sartorius Stedim Biotech SA Announcement
BRIEF published on 01/29/2025 at 12:31, 1 year 1 month ago Sartorius Stedim Biotech: Preliminary Results 2024 EBITDA Sartorius Turnover Results 2024 Outlook 2025
BRIEF published on 01/28/2025 at 07:09, 1 year 1 month ago Sartorius Stedim Biotech Reveals Preliminary 2024 Financial Results Profitability Order Intake Sartorius Stedim Biotech Sales Revenue Financial Results 2024
PRESS RELEASE published on 01/28/2025 at 07:04, 1 year 1 month ago Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024, meeting revenue and profitability targets. Cautiously positive outlook for 2025 with profitable growth expected Financial Results Sartorius Stedim Biotech Profitable Growth Outlook 2024
BRIEF published on 01/07/2025 at 10:18, 1 year 2 months ago Half-yearly report on the liquidity contract of Sartorius Stedim Biotech Liquidity Contract Transactions Kepler Cheuvreux Half-yearly Report Sartorius Stedim Biotech
PRESS RELEASE published on 01/07/2025 at 10:13, 1 year 2 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech Sartorius Stedim Biotech S.A. releases half-year liquidity contract statement with details of shares and executed trades, complying with AMF regulations Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech AMF Regulations
BRIEF published on 01/06/2025 at 11:08, 1 year 2 months ago Number of shares and voting rights of Sartorius Stedim Biotech Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France declares the total number of shares and voting rights in their issued capital according to regulations Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 01/06/2025 at 11:03, 1 year 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital as of December 31, 2024 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
BRIEF published on 12/03/2024 at 10:43, 1 year 3 months ago Sartorius Stedim Biotech Statement on Share Capital Share Capital Voting Rights Actions AMF Sartorius Stedim
Published on 03/23/2026 at 22:40, 1 hour 17 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 1 hour 27 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 1 hour 57 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 2 hours 39 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 9 hours 52 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 22:05, 1 hour 51 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 2 hours 52 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 2 hours 56 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 3 hours 1 minute ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 4 hours 48 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 17:45, 6 hours 11 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 6 hours 12 minutes ago Share buyback for allocation to employees or corporate officers
Published on 03/23/2026 at 17:35, 6 hours 22 minutes ago Disclosure of transactions in own shares from March 16 to March 20, 2026
